Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-in-human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety of GEN1046 in Subjects With Malignant Solid Tumors

NCT03917381 is registered in ClinicalTrials.gov with Genmab as lead sponsor.

NCT NCT03917381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03917381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-in-human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety of GEN1046 in Subjects With Malignant Solid Tumors
Lead sponsor
Genmab
Phase
Phase 1/2
Overall status
Terminated
Start date
May 14, 2019
Completion date
August 3, 2026
Enrollment
429 (actual)
Sites
57

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors